Review



fluconazole flc  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Thermo Fisher fluconazole flc
    Fluconazole Flc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fcz/Fluconazole%2C+98%25/pm42101952-59-7-9
    Average 94 stars, based on 1 article reviews
    fluconazole flc - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Adsorption:

    Article Title: Feedstock doping using iron rich waste increases the pyrolysis gas yield and adsorption performance of magnetic biochar for emerging contaminants.
    Article Snippet: .. Single compound batch adsorption experiments using caffeine (extra pure, Fisher Chemical UK) and fluconazole (> 98%, Acros Organics UK) were conducted to assess the adsorption capacity in the concentration range of 15-320 mg L-1 (fluconazole) and 5-500 mg L-1 (caffeine). ..

    Concentration Assay:

    Article Title: Feedstock doping using iron rich waste increases the pyrolysis gas yield and adsorption performance of magnetic biochar for emerging contaminants.
    Article Snippet: .. Single compound batch adsorption experiments using caffeine (extra pure, Fisher Chemical UK) and fluconazole (> 98%, Acros Organics UK) were conducted to assess the adsorption capacity in the concentration range of 15-320 mg L-1 (fluconazole) and 5-500 mg L-1 (caffeine). ..

    other:

    Article Title: Characterization of Candida spp. from the urinary tract: antifungal susceptibility and virulence traits.
    Article Snippet: Antimicrobial susceptibility of all the isolates for fluconazole (FLC) (Thermo Fisher Scientific, Waltham, MA, USA) and clotrimazole (CLT) (Sigma- Aldrich, St. Louis, MO, USA) was determined using the broth microdilution test according to the methodological standards detailed by the European Committee on Antimicrobial Susceptibility Testing [13].



    Similar Products

    94
    MedChemExpress flc
    SLA1 deletion drives <t>FLC</t> resistance through upregulation of CDR1. (A) Spotting assays of WT and sla1Δ mutants. Strains were spotted onto YPD agar supplemented with the <t>FLC,</t> <t>KTC,</t> AMB and the plates were incubated at 30 for 2 days. (B) RT-qPCR analysis of ERG genes, CDR1 , CDR2 , MDR1 and PMC1 in WT and sla1Δ strains ( n = 3). (C) Spotting assays of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. Indicated strains were spotted with or without FLC. (D) FLC IC₅₀ values of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. (E) Correlation analysis between SLA1 and CDR1 transcript levels in 17 clinical C. auris isolates. (F) RT-qPCR analysis of CDR1 regulators CAP1 , TAC1 , and GSK3 in WT and sla1Δ strains ( n = 3). Two-tailed unpaired t -tests were used for statistical analyses; data are expressed as the mean ± SD.
    Flc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fcz/Fluconazole/pmc13683593-267-7-8
    Average 94 stars, based on 1 article reviews
    flc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Pfizer Inc fluconazole fcz sodium chloride injection
    SLA1 deletion drives <t>FLC</t> resistance through upregulation of CDR1. (A) Spotting assays of WT and sla1Δ mutants. Strains were spotted onto YPD agar supplemented with the <t>FLC,</t> <t>KTC,</t> AMB and the plates were incubated at 30 for 2 days. (B) RT-qPCR analysis of ERG genes, CDR1 , CDR2 , MDR1 and PMC1 in WT and sla1Δ strains ( n = 3). (C) Spotting assays of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. Indicated strains were spotted with or without FLC. (D) FLC IC₅₀ values of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. (E) Correlation analysis between SLA1 and CDR1 transcript levels in 17 clinical C. auris isolates. (F) RT-qPCR analysis of CDR1 regulators CAP1 , TAC1 , and GSK3 in WT and sla1Δ strains ( n = 3). Two-tailed unpaired t -tests were used for statistical analyses; data are expressed as the mean ± SD.
    Fluconazole Fcz Sodium Chloride Injection, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fcz/chloride+fcz+fluconazole+injection+sodium/pm42114577-121-1-6
    Average 86 stars, based on 1 article reviews
    fluconazole fcz sodium chloride injection - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    Thermo Fisher fluconazole flc
    SLA1 deletion drives <t>FLC</t> resistance through upregulation of CDR1. (A) Spotting assays of WT and sla1Δ mutants. Strains were spotted onto YPD agar supplemented with the <t>FLC,</t> <t>KTC,</t> AMB and the plates were incubated at 30 for 2 days. (B) RT-qPCR analysis of ERG genes, CDR1 , CDR2 , MDR1 and PMC1 in WT and sla1Δ strains ( n = 3). (C) Spotting assays of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. Indicated strains were spotted with or without FLC. (D) FLC IC₅₀ values of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. (E) Correlation analysis between SLA1 and CDR1 transcript levels in 17 clinical C. auris isolates. (F) RT-qPCR analysis of CDR1 regulators CAP1 , TAC1 , and GSK3 in WT and sla1Δ strains ( n = 3). Two-tailed unpaired t -tests were used for statistical analyses; data are expressed as the mean ± SD.
    Fluconazole Flc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fcz/Fluconazole%2C+98%25/pm42101952-59-7-9
    Average 94 stars, based on 1 article reviews
    fluconazole flc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Sebia Inc sebia flc elisa
    SLA1 deletion drives <t>FLC</t> resistance through upregulation of CDR1. (A) Spotting assays of WT and sla1Δ mutants. Strains were spotted onto YPD agar supplemented with the <t>FLC,</t> <t>KTC,</t> AMB and the plates were incubated at 30 for 2 days. (B) RT-qPCR analysis of ERG genes, CDR1 , CDR2 , MDR1 and PMC1 in WT and sla1Δ strains ( n = 3). (C) Spotting assays of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. Indicated strains were spotted with or without FLC. (D) FLC IC₅₀ values of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. (E) Correlation analysis between SLA1 and CDR1 transcript levels in 17 clinical C. auris isolates. (F) RT-qPCR analysis of CDR1 regulators CAP1 , TAC1 , and GSK3 in WT and sla1Δ strains ( n = 3). Two-tailed unpaired t -tests were used for statistical analyses; data are expressed as the mean ± SD.
    Sebia Flc Elisa, supplied by Sebia Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fcz/assay+elisa+flc+sebia/pm42097195-109-1-1
    Average 86 stars, based on 1 article reviews
    sebia flc elisa - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Siemens Healthineers n latex flc kappa kit
    Box plots illustrating (a) the number of CSF-specific oligoclonal bands (OCB) of OCB positive persons with MS and CIS, (b) intrathecal produced amount of IgG of persons with MS and CIS with detectable IgG-synthesis, according to Reiber’s diagram, and (c) KFLC index of all persons with MS and CIS with KFLC index >6.1. Panel (d) shows OCB count cross across different clinical presentation types. Boxes represent interquartile range with horizontal line within the box representing the median. Lower and upper whiskers represent min. and max. values. MS, multiple sclerosis; CIS, clinically isolated syndrome; OCB, oligoclonal bands; CSF, cerebrospinal fluid; IgG, immunoglobulin G; KFLC, <t>kappa</t> free light chains.
    N Latex Flc Kappa Kit, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fcz/flc+kappa+kit+latex+n/pmc13133738-87-12-17
    Average 86 stars, based on 1 article reviews
    n latex flc kappa kit - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Sebia Inc n latex κ flc
    Box plots illustrating (a) the number of CSF-specific oligoclonal bands (OCB) of OCB positive persons with MS and CIS, (b) intrathecal produced amount of IgG of persons with MS and CIS with detectable IgG-synthesis, according to Reiber’s diagram, and (c) KFLC index of all persons with MS and CIS with KFLC index >6.1. Panel (d) shows OCB count cross across different clinical presentation types. Boxes represent interquartile range with horizontal line within the box representing the median. Lower and upper whiskers represent min. and max. values. MS, multiple sclerosis; CIS, clinically isolated syndrome; OCB, oligoclonal bands; CSF, cerebrospinal fluid; IgG, immunoglobulin G; KFLC, <t>kappa</t> free light chains.
    N Latex κ Flc, supplied by Sebia Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fcz/flc+latex+n+%CE%BA/pmc12951226-99-9-7
    Average 86 stars, based on 1 article reviews
    n latex κ flc - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Sebia Inc sebia flc elisa assay
    Box plots illustrating (a) the number of CSF-specific oligoclonal bands (OCB) of OCB positive persons with MS and CIS, (b) intrathecal produced amount of IgG of persons with MS and CIS with detectable IgG-synthesis, according to Reiber’s diagram, and (c) KFLC index of all persons with MS and CIS with KFLC index >6.1. Panel (d) shows OCB count cross across different clinical presentation types. Boxes represent interquartile range with horizontal line within the box representing the median. Lower and upper whiskers represent min. and max. values. MS, multiple sclerosis; CIS, clinically isolated syndrome; OCB, oligoclonal bands; CSF, cerebrospinal fluid; IgG, immunoglobulin G; KFLC, <t>kappa</t> free light chains.
    Sebia Flc Elisa Assay, supplied by Sebia Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fcz/assay+elisa+flc+sebia/pmc12951226-57-1-1
    Average 86 stars, based on 1 article reviews
    sebia flc elisa assay - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Sebia Inc involved flc iflc
    Box plots illustrating (a) the number of CSF-specific oligoclonal bands (OCB) of OCB positive persons with MS and CIS, (b) intrathecal produced amount of IgG of persons with MS and CIS with detectable IgG-synthesis, according to Reiber’s diagram, and (c) KFLC index of all persons with MS and CIS with KFLC index >6.1. Panel (d) shows OCB count cross across different clinical presentation types. Boxes represent interquartile range with horizontal line within the box representing the median. Lower and upper whiskers represent min. and max. values. MS, multiple sclerosis; CIS, clinically isolated syndrome; OCB, oligoclonal bands; CSF, cerebrospinal fluid; IgG, immunoglobulin G; KFLC, <t>kappa</t> free light chains.
    Involved Flc Iflc, supplied by Sebia Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fcz/flc+iflc+involved/pmc12951226-91-6-11
    Average 86 stars, based on 1 article reviews
    involved flc iflc - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results


    SLA1 deletion drives FLC resistance through upregulation of CDR1. (A) Spotting assays of WT and sla1Δ mutants. Strains were spotted onto YPD agar supplemented with the FLC, KTC, AMB and the plates were incubated at 30 for 2 days. (B) RT-qPCR analysis of ERG genes, CDR1 , CDR2 , MDR1 and PMC1 in WT and sla1Δ strains ( n = 3). (C) Spotting assays of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. Indicated strains were spotted with or without FLC. (D) FLC IC₅₀ values of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. (E) Correlation analysis between SLA1 and CDR1 transcript levels in 17 clinical C. auris isolates. (F) RT-qPCR analysis of CDR1 regulators CAP1 , TAC1 , and GSK3 in WT and sla1Δ strains ( n = 3). Two-tailed unpaired t -tests were used for statistical analyses; data are expressed as the mean ± SD.

    Journal: Frontiers in Microbiology

    Article Title: SLA1 governs azole resistance in Candidozyma auris via mitochondrial ROS-driven efflux pump expression

    doi: 10.3389/fmicb.2026.1948008

    Figure Lengend Snippet: SLA1 deletion drives FLC resistance through upregulation of CDR1. (A) Spotting assays of WT and sla1Δ mutants. Strains were spotted onto YPD agar supplemented with the FLC, KTC, AMB and the plates were incubated at 30 for 2 days. (B) RT-qPCR analysis of ERG genes, CDR1 , CDR2 , MDR1 and PMC1 in WT and sla1Δ strains ( n = 3). (C) Spotting assays of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. Indicated strains were spotted with or without FLC. (D) FLC IC₅₀ values of WT, sla1Δ , cdr1Δ , and sla1Δcdr1Δ strains. (E) Correlation analysis between SLA1 and CDR1 transcript levels in 17 clinical C. auris isolates. (F) RT-qPCR analysis of CDR1 regulators CAP1 , TAC1 , and GSK3 in WT and sla1Δ strains ( n = 3). Two-tailed unpaired t -tests were used for statistical analyses; data are expressed as the mean ± SD.

    Article Snippet: Drug-resistance tests were performed using 20 μg/mL FLC (MedChemExpress, cat# HY-B0101), 0.2 μg/mL ketoconazole (KTC) (MedChemExpress, cat# HY-B0105), 1.0 μg/mL Amphotericin B (AMB) (MedChemExpress, cat# HY-B0221), 10 mM NAC (Sigma, cat# 1009005), 20 μM Antimycin A (Sigma, cat# 77332), 50 μM Mito-TEMPO (MedChemExpress, cat# HY-112879), 60 μM Rotenone (MedChemExpress, cat# HY-B1756), and 1 mM H2O2 (Sigma, cat# 108600).

    Techniques: Incubation, Quantitative RT-PCR, Analysis, Two Tailed Test

    SLA1 deletion disrupts redox homeostasis and mitochondrial energy metabolism to regulate FLC resistance in C. auris . (A) GO analyses. GO term enrichment analyses were performed using the RNA-seq data from WT and sla1Δ strains. (B,C) Gene Set Enrichment Analysis (GSEA). Comparing the transcriptome data from the WT and sla1Δ strains. (D) Spotting assays of WT and sla1Δ strains. Strains were spotted onto YPD agar supplemented FLC, FLC + NAC, or FLC + H₂O₂ conditions. (E) Flow cytometry analysis of intracellular ROS levels in WT, and sla1Δ strains. Wild-type and sla1Δ cells were cultured YPD, loaded with MitoSOX, and then analyzed by flow cytometry. (F) Analysis of ROS levels. WT and sla1Δ strains were incubated at 30 °C for 12 h, then ROS levels were measured ( n = 4). (G) Analysis of ATP levels. WT and sla1Δ strains were incubated at 30 °C, then ATP levels were measured ( n = 3). (H) RT-qPCR analysis of genes involved in mitochondrial respiration and energy metabolism in WT and sla1Δ strains ( n = 3). (I) Analysis of ATP and ROS levels. Measurement of relative intracellular ATP and ROS content in laboratory wild-type susceptible strain and five clinical fluconazole-resistant C. auris isolates. ( n = 3). Two-tailed unpaired t -tests were used for statistical analyses; data are expressed as the mean ± SD.

    Journal: Frontiers in Microbiology

    Article Title: SLA1 governs azole resistance in Candidozyma auris via mitochondrial ROS-driven efflux pump expression

    doi: 10.3389/fmicb.2026.1948008

    Figure Lengend Snippet: SLA1 deletion disrupts redox homeostasis and mitochondrial energy metabolism to regulate FLC resistance in C. auris . (A) GO analyses. GO term enrichment analyses were performed using the RNA-seq data from WT and sla1Δ strains. (B,C) Gene Set Enrichment Analysis (GSEA). Comparing the transcriptome data from the WT and sla1Δ strains. (D) Spotting assays of WT and sla1Δ strains. Strains were spotted onto YPD agar supplemented FLC, FLC + NAC, or FLC + H₂O₂ conditions. (E) Flow cytometry analysis of intracellular ROS levels in WT, and sla1Δ strains. Wild-type and sla1Δ cells were cultured YPD, loaded with MitoSOX, and then analyzed by flow cytometry. (F) Analysis of ROS levels. WT and sla1Δ strains were incubated at 30 °C for 12 h, then ROS levels were measured ( n = 4). (G) Analysis of ATP levels. WT and sla1Δ strains were incubated at 30 °C, then ATP levels were measured ( n = 3). (H) RT-qPCR analysis of genes involved in mitochondrial respiration and energy metabolism in WT and sla1Δ strains ( n = 3). (I) Analysis of ATP and ROS levels. Measurement of relative intracellular ATP and ROS content in laboratory wild-type susceptible strain and five clinical fluconazole-resistant C. auris isolates. ( n = 3). Two-tailed unpaired t -tests were used for statistical analyses; data are expressed as the mean ± SD.

    Article Snippet: Drug-resistance tests were performed using 20 μg/mL FLC (MedChemExpress, cat# HY-B0101), 0.2 μg/mL ketoconazole (KTC) (MedChemExpress, cat# HY-B0105), 1.0 μg/mL Amphotericin B (AMB) (MedChemExpress, cat# HY-B0221), 10 mM NAC (Sigma, cat# 1009005), 20 μM Antimycin A (Sigma, cat# 77332), 50 μM Mito-TEMPO (MedChemExpress, cat# HY-112879), 60 μM Rotenone (MedChemExpress, cat# HY-B1756), and 1 mM H2O2 (Sigma, cat# 108600).

    Techniques: RNA Sequencing, Analysis, Flow Cytometry, Cell Culture, Incubation, Quantitative RT-PCR, Two Tailed Test

    Box plots illustrating (a) the number of CSF-specific oligoclonal bands (OCB) of OCB positive persons with MS and CIS, (b) intrathecal produced amount of IgG of persons with MS and CIS with detectable IgG-synthesis, according to Reiber’s diagram, and (c) KFLC index of all persons with MS and CIS with KFLC index >6.1. Panel (d) shows OCB count cross across different clinical presentation types. Boxes represent interquartile range with horizontal line within the box representing the median. Lower and upper whiskers represent min. and max. values. MS, multiple sclerosis; CIS, clinically isolated syndrome; OCB, oligoclonal bands; CSF, cerebrospinal fluid; IgG, immunoglobulin G; KFLC, kappa free light chains.

    Journal: Frontiers in Neurology

    Article Title: Assessing the value of oligoclonal band count in multiple sclerosis: insights from a large cohort analysis

    doi: 10.3389/fneur.2026.1719470

    Figure Lengend Snippet: Box plots illustrating (a) the number of CSF-specific oligoclonal bands (OCB) of OCB positive persons with MS and CIS, (b) intrathecal produced amount of IgG of persons with MS and CIS with detectable IgG-synthesis, according to Reiber’s diagram, and (c) KFLC index of all persons with MS and CIS with KFLC index >6.1. Panel (d) shows OCB count cross across different clinical presentation types. Boxes represent interquartile range with horizontal line within the box representing the median. Lower and upper whiskers represent min. and max. values. MS, multiple sclerosis; CIS, clinically isolated syndrome; OCB, oligoclonal bands; CSF, cerebrospinal fluid; IgG, immunoglobulin G; KFLC, kappa free light chains.

    Article Snippet: Serum and CSF concentrations of KFLC were measured using nephelometry with the N Latex FLC kappa kit (Siemens Healthcare Diagnostics Products GmbH), following the manufacturer’s instructions on an Atellica Neph 630 System (Siemens Healthcare Diagnostics Products GmbH).

    Techniques: Produced, Isolation

    Receiver operating characteristic (ROC) curves for the differentiation of MS and CIS ( n = 269). The plot illustrates the diagnostic accuracy of OCB count, KFLC index, intrathecal IgG synthesis according to Reiber, and the combination of OCB count and KFLC index. The area under the curve (AUC) with corresponding 95% confidence interval (CI) for each methodology is indicated in the legend. The distinct inflection point in the intrathecal IgG curve reflects the high proportion of individuals with a calculated IgG synthesis of 0.0 mg/L, where the methodology reaches its limit of continuous discrimination. MS, multiple sclerosis; CIS, clinically isolated syndrome; OCB, oligoclonal bands; KFLC, kappa free light chain; IgG, immunoglobulin G.

    Journal: Frontiers in Neurology

    Article Title: Assessing the value of oligoclonal band count in multiple sclerosis: insights from a large cohort analysis

    doi: 10.3389/fneur.2026.1719470

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves for the differentiation of MS and CIS ( n = 269). The plot illustrates the diagnostic accuracy of OCB count, KFLC index, intrathecal IgG synthesis according to Reiber, and the combination of OCB count and KFLC index. The area under the curve (AUC) with corresponding 95% confidence interval (CI) for each methodology is indicated in the legend. The distinct inflection point in the intrathecal IgG curve reflects the high proportion of individuals with a calculated IgG synthesis of 0.0 mg/L, where the methodology reaches its limit of continuous discrimination. MS, multiple sclerosis; CIS, clinically isolated syndrome; OCB, oligoclonal bands; KFLC, kappa free light chain; IgG, immunoglobulin G.

    Article Snippet: Serum and CSF concentrations of KFLC were measured using nephelometry with the N Latex FLC kappa kit (Siemens Healthcare Diagnostics Products GmbH), following the manufacturer’s instructions on an Atellica Neph 630 System (Siemens Healthcare Diagnostics Products GmbH).

    Techniques: Diagnostic Assay, Isolation

    Scatter plots showing the positive correlations between the number of oligoclonal bands (OCB) in CSF with (a) intrathecal IgG levels (rho = 0.6963, p < 0.0001) and (b) KFLC index (rho = 0.7099, p < 0.0001). MS, multiple sclerosis; OCB, oligoclonal bands; CSF, cerebrospinal fluid; KFLC, kappa free light chains; EDSS, IgG, immunoglobulin G.

    Journal: Frontiers in Neurology

    Article Title: Assessing the value of oligoclonal band count in multiple sclerosis: insights from a large cohort analysis

    doi: 10.3389/fneur.2026.1719470

    Figure Lengend Snippet: Scatter plots showing the positive correlations between the number of oligoclonal bands (OCB) in CSF with (a) intrathecal IgG levels (rho = 0.6963, p < 0.0001) and (b) KFLC index (rho = 0.7099, p < 0.0001). MS, multiple sclerosis; OCB, oligoclonal bands; CSF, cerebrospinal fluid; KFLC, kappa free light chains; EDSS, IgG, immunoglobulin G.

    Article Snippet: Serum and CSF concentrations of KFLC were measured using nephelometry with the N Latex FLC kappa kit (Siemens Healthcare Diagnostics Products GmbH), following the manufacturer’s instructions on an Atellica Neph 630 System (Siemens Healthcare Diagnostics Products GmbH).

    Techniques: